Target intelligence / Profile preview

Immunoglobulin heavy joining 2P (pseudogene) (IGHJ2P)

Target
IGHJ2P
Molecular classification
Other (Pseudogene)
01

Overview

Immunoglobulin heavy joining 2P (IGHJ2P) is a pseudogene segment located within the immunoglobulin heavy chain locus (IGH) on chromosome 14q32.33. The IGH locus contains multiple functional and nonfunctional gene segments involved in generating antibody diversity through V(D)J recombination, but IGHJ2P is pseudogenized (incapable of encoding a protein) and thus does not contribute to antibody production[1][8][10]. Pseudogenes within the IGH locus arise by truncation, mutation, or deletion and serve as markers of genomic variation rather than active biological roles. IGHJ2P is not a receptor, enzyme, transporter, or other canonical drug target and has no known physiological or pathological significance. The primary aliases in scientific literature are JPSI2 or Jpsi2, but these are rarely used compared to IGHJ2P. IGHJ2P is not a functional gene, therapeutic target, or biomarker; it is a pseudogene and should not be considered for receptor, enzyme, or drug target analysis[1][8][10].

Other names
Jpsi2JPSI2
02

Biological functions

Other (No known biological function as it is a pseudogene; functional joining segments contribute to antibody diversity, but IGHJ2P does not.)
03

Disease associations

Other (No direct disease association; functional IGHJ genes, not IGHJ2P, are implicated in immunodeficiencies and lymphoid malignancies[3][10].)

Beyond the preview

Go deeper on Immunoglobulin heavy joining 2P (pseudogene) (IGHJ2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy joining 2P (pseudogene) (IGHJ2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call